期刊文献+

瑞波西汀的非抗抑郁应用 被引量:2

下载PDF
导出
摘要 瑞波西汀是一种选择性去甲肾上腺素(NE)回收抑制剂,主要用于抗抑郁治疗。但除了这一主要效应外,瑞波西汀还广泛应用于精神科其他领域,本文拟综合瑞波西汀在焦虑障碍、精神分裂症、儿童精神障碍、贪食和肥胖、物质依赖及其他疾病中的应用。 1焦虑障碍 从病因上考虑,5-羟色胺(5-HT)稳定心境,降低则心境不稳,易感焦虑,服选择性5-HT回收抑制剂(SSRIs)有效;
作者 喻东山
出处 《四川精神卫生》 2012年第1期57-61,共5页 Sichuan Mental Health
  • 相关文献

参考文献31

  • 1Bertani A,Perna G,Migliarese G,et al.Comparison of the treatment with paroxetine and reboxetine in panic disorder:a randomized,single-blind study[J].Pharmacopsychiatry,2004,37(5):206-210.
  • 2Agelink MW,Ullrich H,Baumann B,et al.Effects of reboxetine,a selective norepinephrine reuptake inhibitor,on sympathetic and parasympathetic outflow to the heart:preliminary data[J].Psycho-pharmacology(Berl),2002,163(2):151-156.
  • 3Krell HV,Leuchter AF,Cook LA,et al.Evaluation of reboxetine,a noradrenergic antidepressant,for the treatment of fibromyalgia and chronic low lack pain[J].Psychosomatics,2005,46(5):379-384.
  • 4Pacchiarotti I,Manfredi G,Kotzalidis GD,et al.A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine[J].Eur Psychiatry,2004,19(4):233-234.
  • 5Tse WS,Band AJ.Reboxetine promotes social bonding in volunteers[J].J Psychopharmacol,2003,17(2):189-195.
  • 6Spivak B,Strous RD,Shaked D,et al.Reboxetine versus fluvoxam-ine in the treatment of motor vehicle accident-related posttraumat-ic stress disorder:a double-blind,fixed-dosage,controlled trial[J].J Clin Psychopharmacol,2006,26(3):152-156.
  • 7Kitaichi Y,Inoue T,Nakagawa S,et al.Effect of coadministration of lithium and reboxetine on extracellular monoamine concentration in rats[J].Eur J Pharmacol,2004,489(3):187-191.
  • 8Raedler TJ,Jahn H,Arlt J,et al.Adjunctive use of reboxetine in schizophrenia[J].Eur Psychiatry,2004,19(6):366-369.
  • 9Schutz G,Berk M.Reboxetine add on therapy to haloperidol in the treatment of schizophrenia:a preliminary double-blind randomized placebo-controlled study[J].Int Clin Psychopharmacol,2001,16(5):275-278.
  • 10Poyurovsky M,Fuchs C,Pashinian A,et al.Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizo-phrenia patients:a double-blind placebo-controlled study[J].Psychopharmacology(Berl),2007,192(3):441-448.

同被引文献24

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部